Report Detail
LivaNova PLC (LIVN) - Product Pipeline Analysis, 2018 Update
- RnM2733827 |
- 07 January, 2019 |
- Global |
- 58 Pages |
- GlobalData |
- Medical Devices & Consumables
Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for auto transfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, England, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LivaNova PLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
LivaNova PLC Company Overview 6
LivaNova PLC Company Snapshot 6
LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 6
LivaNova PLC – Pipeline Analysis Overview 9
LivaNova PLC - Key Facts 9
LivaNova PLC - Major Products and Services 10
LivaNova PLC Pipeline Products by Development Stage 11
LivaNova PLC Ongoing Clinical Trials by Trial Status 14
LivaNova PLC Pipeline Products Overview 16
Aspire NP 16
Aspire NP Product Overview 16
Caisson TMVR System 17
Caisson TMVR System Product Overview 17
Caisson TMVR System Clinical Trial 18
Centro Generator 19
Centro Generator Product Overview 19
CentroSR Generator 20
CentroSR Generator Product Overview 20
Equilia 21
Equilia Product Overview 21
Griffin - Pulse Generator 22
Griffin - Pulse Generator Product Overview 22
Intense Neuromodulation System - Heart Failure 23
Intense Neuromodulation System - Heart Failure Product Overview 23
LBATS 24
LBATS Product Overview 24
Microburst VNS Stimulator 25
Microburst VNS Stimulator Product Overview 25
Microburst VNS Stimulator Clinical Trial 26
Nerve Wrap 27
Nerve Wrap Product Overview 27
New Oxy Apex HP Oxygenator 28
New Oxy Apex HP Oxygenator Product Overview 28
Next Generation ECMO System 29
Next Generation ECMO System Product Overview 29
Next Generation Wand - VNS Therapy 30
Next Generation Wand - VNS Therapy Product Overview 30
NINO 31
NINO Product Overview 31
Pediatric pVAD 32
Pediatric pVAD Product Overview 32
Perceval S – Extended Indications 33
Perceval S – Extended Indications Product Overview 33
Perceval S – Extended Indications Clinical Trial 34
Perceval Sutureless Heart Valve 35
Perceval Sutureless Heart Valve Product Overview 35
Perceval Sutureless Heart Valve Clinical Trial 36
Percutaneous Mitral Valve Repair Device 38
Percutaneous Mitral Valve Repair Device Product Overview 38
Percutaneous Mitral Valve Replacement Device 39
Percutaneous Mitral Valve Replacement Device Product Overview 39
PhoenixRF SR 40
PhoenixRF SR Product Overview 40
ProGuardian System 41
ProGuardian System Product Overview 41
Remote Monitoring System V2 42
Remote Monitoring System V2 Product Overview 42
Spiderflash AFIB 43
Spiderflash AFIB Product Overview 43
VITARIA System - Chronic Heart Failure 44
VITARIA System - Chronic Heart Failure Product Overview 44
VITARIA System - Chronic Heart Failure Clinical Trial 45
LivaNova PLC - Key Competitors 46
LivaNova PLC - Key Employees 47
LivaNova PLC - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
LivaNova PLC , Recent Developments 49
Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49
Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49
Jun 13, 2018: LivaNova Welcomes William Kozy to Board of Directors 50
May 30, 2018: LivaNova Comments on the U.S. Centers for Medicare & Medicaid Services’ Reconsideration of its National Coverage Determination for VNS Therapy for Treatment-Resistant Depression 50
Apr 26, 2018: LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient 50
Apr 17, 2018: LivaNova Receives CE Mark for VNS Therapy SenTiva Generator and Next-Generation Programming System for Treatment of Epilepsy 51
Mar 29, 2018: LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients 51
Mar 28, 2018: LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System 52
Mar 22, 2018: LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China 52
Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 53
Appendix 55
Methodology 55
About GlobalData 58
Contact Us 58
Disclaimer 58
Summary:
Get latest Market Research Reports on LivaNova PLC (LIVN) . Industry analysis & Market Report on LivaNova PLC (LIVN) is a syndicated market report, published as LivaNova PLC (LIVN) - Product Pipeline Analysis, 2018 Update. It is complete Research Study and Industry Analysis of LivaNova PLC (LIVN) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
